Medicare Enrolled

Dr. Alison Rome, MD

Hematology & Oncology · Houston, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
11920 ASTORIA BLVD STE 240, Houston, TX 77089
8329321730
In practice since 2007 (18 years)
NPI: 1790998078 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rome from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rome? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rome

Dr. Alison Rome is a hematology & oncology specialist in Houston, TX, with 18 years of NPI registration. Based on federal Medicare data, Dr. Rome performed 735 Medicare services across 338 unique beneficiaries.

Between the years covered by Open Payments, Dr. Rome received a total of $10,390 from 77 pharmaceutical and/or device companies across 437 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rome is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ 735 Medicare services $10,390 industry payments

Medicare Practice Summary

Medicare Utilization ↗
735
Medicare services
Bottom 42% in TX for hematology & oncology
338
Unique beneficiaries
$64
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~41 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, moderate complexity 233 $63 $247
Office visit, established patient (30-39 min) 86 $98 $368
Blood draw (venipuncture) 85 $8 $20
Complete blood count (CBC) with differential 79 $8 $36
Initial hospital admission, moderate complexity 47 $104 $470
Comprehensive metabolic blood panel 44 $10 $64
Administration of chemotherapy into vein, 1 hour or less 36 $102 $707
Hospital follow-up visit, high complexity 35 $96 $357
Office visit, established patient, complex (40-54 min) 30 $138 $496
New patient office visit (45-59 min) 25 $124 $565
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 20 $41 $313
Initial hospital admission, high complexity 15 $140 $694
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.7% high complexity
4.9% medium
92.4% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$10,390
Total received (2018-2024)
Avg $1,484/year across 7 years
Top 31% in TX for hematology & oncology
77
Companies
437
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,003 (86.6%)
Other
Charitable contributions, space rental, and other categories
$932 (9.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$456 (4.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,649
2023
$2,343
2022
$520
2021
$12
2020
$437
2019
$1,772
2018
$1,658

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$1,382
PFIZER INC.
$806
Amgen Inc.
$663
AstraZeneca Pharmaceuticals LP
$615
E.R. Squibb & Sons, L.L.C.
$601
Genentech USA, Inc.
$550
Janssen Biotech, Inc.
$387
Astellas Pharma US Inc
$375
Merck Sharp & Dohme LLC
$303
Celgene Corporation
$255
GENZYME CORPORATION
$246
Lilly USA, LLC
$241
Merck Sharp & Dohme Corporation
$236
GlaxoSmithKline, LLC.
$201
Gilead Sciences, Inc.
$185
Ipsen Biopharmaceuticals, Inc
$176
PharmaEssentia USA Corporation
$162
Daiichi Sankyo Inc.
$157
TESARO, Inc.
$143
Rigel Pharmaceuticals, Inc.
$133
SOBI, INC
$127
Eisai Inc.
$116
TerSera Therapeutics LLC
$112
TAIHO ONCOLOGY, INC.
$104
Takeda Pharmaceuticals U.S.A., Inc.
$102
SANOFI-AVENTIS U.S. LLC
$100
Boehringer Ingelheim Pharmaceuticals, Inc.
$84
Bayer HealthCare Pharmaceuticals Inc.
$78
Dendreon Pharmaceuticals LLC
$78
Deciphera Pharmaceuticals Inc.
$74
EMD Serono, Inc.
$72
Exelixis Inc.
$70
PUMA BIOTECHNOLOGY, INC.
$61
JAZZ PHARMACEUTICALS INC.
$60
Alexion Pharmaceuticals, Inc.
$59
Pharmacyclics LLC, An AbbVie Company
$59
Janssen Pharmaceuticals, Inc
$59
Pharming Healthcare, Inc.
$58
Seagen Inc.
$54
Incyte Corporation
$52
ABBVIE INC.
$50
EISAI INC.
$49
BeiGene USA, Inc.
$49
SpringWorks Therapeutics, Inc.
$46
Tempus AI, Inc
$43
Regeneron Healthcare Solutions, Inc.
$42
Jazz Pharmaceuticals Inc.
$42
MorphoSys, US Inc.
$36
Boston Scientific Corporation
$34
Puma Biotechnology, Inc.
$32
Kite Pharma, Inc.
$31
AVEO Pharmaceuticals, Inc.
$30
Bayer Healthcare Pharmaceuticals Inc.
$30
ARRAY BIOPHARMA INC
$29
Aveo Pharmaceuticals, Inc.
$28
Fennec Pharmaceuticals, Inc.
$27
Pharmacosmos Therapeutics Inc.
$27
Sirtex Medical Inc
$25
AbbVie Inc.
$24
Octapharma USA, Inc.
$23
Immunocore Limited
$22
Myriad Genetic Laboratories, Inc.
$22
Karyopharm Therapeutics Inc.
$20
AMAG Pharmaceuticals, Inc.
$20
Global Blood Therapeutics, Inc.
$20
APO-PHARMA USA, INC.
$19
Teva Pharmaceuticals USA, Inc.
$19
Blueprint Medicines Corporation
$18
Clovis Oncology, Inc.
$17
Agios Pharmaceuticals, Inc.
$17
Mirati Therapeutics, Inc.
$16
INSYS Therapeutics Inc
$15
Aurobindo Pharma USA, Inc.
$15
Mylan Institutional Inc.
$15
Akcea Therapeutics, Inc.
$14
Tactile Systems Technology Inc
$14
Acrotech Biopharma LLC
$12
Top 3 companies account for 27.4% of total payments
Associated products mentioned in payments ›
ADCETRIS · ALIMTA · ALUNBRIG · AYVAKIT · Abraxane · Alecensa · Aranesp · Avastin · BELEODAQ · BENDEKA · BESREMI · BOSULIF · BRACANALYSIS CDX · BRUKINSA · Bavencio · Beleodaq · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CHANTIX · CYRAMZA · Cabometyx · Columvi · DARZALEX · DOPTELET · Doptelet · ELELYSO · ELIQUIS · ELREXFIO · ENHERTU · ENJAYMO · ERBITUX · ERLEADA · Enhertu · Erleada · FERAHEME · FERRIPROX · FLEXITOUCH · FOTIVDA · FRUZAQLA · Fabhalta · Fulphila · GILOTRIF · Halaven · IBRANCE · IDHIFA · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Imbruvica · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MONOFERRIC · NERLYNX · Neulasta · Nexavar · Nplate · OCTAPLAS · OGSIVEO · OJJAARA · OPDIVO · OPDUALAG · OXBRYTA · Onivyde · PADCEV · PROMACTA · PROVENGE · Padcev · Pedmark · Perjeta · Pomalyst · Prolia · QINLOCK · REBLOZYL · RETEVMO · RUCONEST · RYBREVANT · RYDAPT · Rezlidhia · Rubraca · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · SUTENT · SYNDROS · Somatuline Depot · Stivarga · TABRECTA · TAGRISSO · TECENTRIQ · TECVAYLI · TEGSEDI · Tavalisse · TheraSphere Y90 Glass Microspheres 10 GBq · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · VYXEOS · Vectibix · Venclexta · Vyloy · XALKORI · XARELTO · XPOVIO · XT CDX · XTANDI · Xospata · Xtandi · ZEJULA · ZEPZELCA · ZOLADEX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (87%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $1,414 per 100 Medicare services performed
Looking for a hematology & oncology specialist in Houston?
Compare hematology & oncology specialists in the Houston area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
197
Per 100K population
4.1
County median income
$73,104
Nearest hospital
HCA HOUSTON HEALTHCARE SOUTHEAST
4.7 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Rome is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 18 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Rome experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Rome performed 233 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rome receive payments from pharmaceutical companies?
Yes. Dr. Rome received a total of $10,390 from 77 companies across 437 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rome's costs compare to other hematology & oncology specialists in Houston?
Dr. Rome's average Medicare payment per service is $64. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rome) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →